Cole-Parmer Recognized as COVID-19 Vaccine Partner

vaccine and syringe

BioNTech recognized its partners for COVID-19 vaccine efforts.

BioNTech acknowledged its partners who have played a pivotal role in their COVID-19 vaccine efforts. Cole-Parmer is proud to be named as one of its partners. BioNTech, in partnership with Pfizer, developed and distributed the first COVID-19 vaccine in 2020.

Cole-Parmer is proud to be an official partner in Project Lightspeed. The relentless support of our employees in this successful collaboration with BioNTech has played a pivotal role in this historic milestone advancing BNT162b2 to become the first approved COVID-19 vaccine for emergency use around the globe.

Read the entire announcement

If you are involved in vaccine design, production or distribution, find out how we can support your project.

Vaccine research and development

Vaccine and therapeutics production

Vaccine distribution


Learn more about Vaccine Research and Development: Vaccine Development: Pathogens Fighting Disease

Be the first to comment on "Cole-Parmer Recognized as COVID-19 Vaccine Partner"

Leave a comment

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: